Merck trades lower after 1Q results

Uptrend
Blue avatar for FOREX.com guest contributors
By :  ,  Financial Analyst
Merck KGaA, the chemicals and pharmaceuticals group, posted 1Q net income surged to 458 million euros from 190 million euros in the prior-year period and adjusted EBITDA rose 27.2% on year to 1.18 billion euros on revenue of 4.37 billion euros, up 16.7%. Regarding full-year outlook, the company said: "Group EBITDA pre is expected to be in a range of between E4.35 billion and E4.85 billion. Owing to strong restrictions of economic life and declining income in the context of the Covid-19 pandemic with correspondingly adverse effects on the businesses, Merck forecasts a merely stable organic development."

From a technical perspective, the bearish gap opened this morning calls for a short term consolidation move. However, the trend remains bullish.  A pennant pattern is taking shape. (Continuation trend pattern).  The daily Relative Strength Index (RSI, 14) is above 50% and is not overbought (<70%).

As long as 95E is support, the bias is bullish. The validation of the pennant pattern would call for a new rise towards 110E and 118.4E.

Alternatively, a break below 95E would negate the bullish view and would call for a reversal down trend with 87.45E as first target.

Market chart demonstrating Merck Trades Lower After 1Q Results. Published in May 2020 by FOREX.com

Source: GAIN Capital, TradingView

 

Open an account in minutes

Experience award-winning platforms with fast and secure execution.

Live Trading Webinars

Our interactive webinars, led by our industry experts, come highly recommended and can help provide your trading with the edge it needs.
Economic Calendar